Yubo International Biotech Limited (YBGJ)

Market Cap	6.05M
Revenue (ttm)	3.47K
Net Income (ttm)	-1.78M
Shares Out	119.82M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,192
Average Volume	6,150
Open	0.0545
Previous Close	0.0500
Day's Range	0.0545 - 0.0545
52-Week Range	0.0310 - 1.3700
Beta	1.12
RSI	50.52
Earnings Date	Apr 11, 2025

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2024, YBGJ's revenue was $3,470, a decrease of -99.43% compared to the previous year's $604,676. Losses were -$1.78 million, 48.6% more than in 2023.